Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors
Clinical trial NCT02610361 · COMPLETED
Trial details
- NCT number
- NCT02610361
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-20
- Primary completion
- 2017-10-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.